Release Date: June 29, 2018
Expiration Date: June 29, 2019
Media: Internet - based
This Community Practice Connections™ focuses on multidisciplinary approaches for the prophylaxis of venous thromboembolism (VTE) in hospitalized adult patients. VTE, which can take the form of deep vein thrombosis and/or pulmonary embolism, affects approximately 900,000 Americans each year and leads to death in approximately 100,000 Americans annually. In addition to the morbidity and mortality, VTE is associated with substantial health care costs. Under-prescribing for VTE prophylaxis may exacerbate the issue. Keeping health care providers apprised of current guidelines and therapies for VTE prophylaxis can improve patient outcomes.
This activity features video interviews with 2 leading cardiologists who discuss VTE risks and guideline recommendations for VTE prevention in specific hospitalized patient populations as well as considerations for extended VTE prophylaxis. Updates from the 2018 American College of Cardiology meeting are shared along with key points that every practitioner should know about prophylaxis of VTE.
Acknowledgement of Commercial Support
This activity is supported by an independent educational grant from Portola Pharmaceuticals, Inc.
Instructions for This Activity and Receiving Credit
You will need to login to participate in the activity.
Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
At the end of the activity, “educational content/video files” will be available for your reference.
In order to receive a CME/CE certificate, participants must complete the activity.
Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.
This educational activity is intended for cardiologists, hematologists, hospitalists, residents, surgeons, anesthesiologists, and other hospital-based providers who care for patients with VTE.
At the conclusion of this activity,you should be better prepared to:
Explain the importance of multidisciplinary approaches to VTE prophylaxis
Identify the pathophysiological processes that underlie venous thromboembolism
Determine appropriate pharmacotherapy for VTE prophylaxis based on patient characteristics and drug properties
Faculty, Staff, and Planners’ Disclosures
Geoffrey Barnes, MD, MSc
Assistant Professor of Internal Medicine
Frankel Cardiovascular Center
University of Michigan Medical School
Ann Arbor, Michigan
Grants/Research Support: Blue Cross Blue Shield of Michigan, Bristol-Myers Squibb, NHLBI, Pfizer; Consultant/Speakers Bureau: Bristol-Myers Squibb, Janssen, Pfizer, Portola
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Executive Director of Interventional Cardiovascular Programs
Brigham and Women’s Hospital Heart & Vascular Center
Professor of Medicine, Harvard Medical School
Grants/Research Support: Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood Pharmaceuticals, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi-Aventis, The Medicines Company
The staff of PER® have no relevant financial relationships with commercial interests to disclose.
Disclosure Policy and Resolution of Conflicts of Interest (COI)
As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.
Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.